George Sellers

Stock Analyst at Stephens & Co.

(1.08)
# 3,842
Out of 5,128 analysts
44
Total ratings
29.41%
Success rate
-6.89%
Average return

Stocks Rated by George Sellers

Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115$145
Current: $113.73
Upside: +27.49%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $70.01
Upside: -2.87%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275$290
Current: $126.53
Upside: +129.19%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56$58
Current: $40.35
Upside: +43.74%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151$178
Current: $137.27
Upside: +29.67%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.84
Upside: +143.90%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $27.69
Upside: +160.02%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8$5
Current: $3.46
Upside: +44.51%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $2.86
Upside: +774.13%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $22.19
Upside: +156.87%